Cerevasc today announced the first-in-human use of its eShunt system to treat medically refractory idiopathic intracranial hypertension (IIH).

CereVasc, Inc., a clinical-stage medical device company developing novel minimally invasive treatments for neurological diseases, today announced the publication of a first-in-human case report ...

At age 66, Richard "Dick" Nash first suspected something might be wrong when he participated in a Dallas walk for juvenile ...

Doctors at Aster Prime Hospitals in Hyderabad successfully treated a 43-year-old man who suffered cardiac arrest during brain ...

USD/CHF ticks lower to near 0.7700 while the US Dollar trades broadly stable. Investors await FOMC Minutes and the US Q4 GDP data for fresh cues on the Fed’s monetary policy outlook. Swiss economy ...

President Trump said he plans to raise his new global tariff to 15%. It would replace many of the duties the Supreme Court ruled illegal. WSJ’s Ashby Jones explains the implications of the court’s ...

Richard Pitino is in his first year as Xavier's coach. He signed a reported six-year deal with the program in March 2025, but could leave the Musketeers early. On Wednesday, analyst Jeff Goodman ...

Indian equity benchmark indices, the Sensex and Nifty, opened in the red on Friday, February 20, 2026, amid weak global cues and sustained FII pressure, with DIIs also turning net sellers in the ...

A little over two weeks before Opening Day, Paul Mainieri received news no coach ever wants to hear. South Carolina’s potential ace, Jake McCoy, suffered a UCL tear in his elbow that required Tommy ...

Radiomics extracts quantitative data from medical images, but its role in predicting deterioration after traumatic brain ...

The surgical team faced an immediate and complex challenge. In neurosurgery, the patient's head is typically elevated to manage intracranial pressure, a position that makes standard CPR ...

Avalo Therapeutics (NASDAQ:AVTX) used a presentation at its 46th Annual Healthcare Conference appearance to outline its strategy for AVTX-009, a high-affinity human monoclonal antibody designed to ...